ARCHIVES

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Programs: First Raid Awardees, Drug Development Projects, Listed

March 26, 1999

Advocacy: Friends To Continue Another Year

June 13, 1997

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977